ELISKARDIA 5mg film-coated tablets medication leaflet

B01AC22 • prasugrel • Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Prasugrel is an antiplatelet medication used to prevent blood clots in patients with acute coronary syndromes (ACS) or those who have undergone percutaneous coronary intervention (PCI).
It works by inhibiting platelet activation, thereby reducing the risk of major cardiovascular events such as heart attack or stroke.

Prasugrel is usually administered in combination with aspirin as part of dual antiplatelet therapy.
The medication is particularly indicated for patients at high risk of thrombotic complications but is not recommended for those with a history of stroke or transient ischemic attack.

Common side effects include bleeding, bruising, and, less commonly, anemia or allergic reactions.
It is important for patients to inform their doctor about any other medications they are taking, as prasugrel may interact with anticoagulants or other drugs affecting blood clotting.

Prasugrel should be used with caution in patients over 75 years of age or those weighing less than 60 kg, as they are at higher risk of bleeding.
Patients should strictly follow their doctor's recommendations and not discontinue treatment without medical advice.